Brann D W, Greenbaum L, Mahesh V B, Gao X
Department of Physiology, Medical College of Georgia, Augusta 30912.
Endocrinology. 1995 Jan;136(1):46-51. doi: 10.1210/endo.136.1.7828557.
Bradykinin is a potent inducer of uterine smooth muscle contractions in rodents and primates. Hence, the purpose of the present study was to characterize the various components of the kinin system in the plasma, uterus, hypothalamus, and anterior pituitary of the rat during pregnancy to determine whether the kinin system is involved in the regulation of uterine contractility during pregnancy. To achieve this aim, timed pregnant rats were used, groups of animals (n = 6 per group) were killed on days 5, 15, 20, 21, and 22, and measurements of kininogen and kallikrein activity were performed on plasma and selected tissues. A nonpregnant control group was also used, consisting of a group of 10 randomly cycling rats. The results of the study revealed that total kininogen levels in the plasma rose during pregnancy (days 15-22) to peak on day 22, the day of parturition. This rise was due to increases primarily in T-kininogen compared to low mol wt (LMW) kininogen. Total kininogen levels in the hypothalamus were undetectable during pregnancy; however, anterior pituitary kininogen levels increased markedly from days 15-22. Hypothalamic kallikrein activity was very markedly increased from days 5-20 only to drop on days 21 and 22 of pregnancy. Uterine total kininogen levels were low from days 5-20 of pregnancy, only to undergo a marked elevation on days 21 and 22 (the day of parturition). This elevation on day 21 was due to increased T- and LMW kininogen levels. Uterine LMW kininogen levels were elevated on day 21, followed by a marked fall on day 22. This fall was most likely due to increased bradykinin production from LMW kininogen, because uterine kallikrein activity was significantly elevated on days 21 and 22. The increased production of bradykinin in the uterus on the day of parturition could play a significant role in the mechanism responsible for activation of uterine contractions during this event.
缓激肽是啮齿动物和灵长类动物子宫平滑肌收缩的强效诱导剂。因此,本研究的目的是表征大鼠孕期血浆、子宫、下丘脑和垂体前叶中激肽系统的各个组成部分,以确定激肽系统是否参与孕期子宫收缩的调节。为实现这一目标,使用了定时怀孕的大鼠,在第5、15、20、21和22天处死动物组(每组n = 6),并对血浆和选定组织进行激肽原和激肽释放酶活性的测量。还使用了一个非怀孕对照组,由一组10只随机处于发情周期的大鼠组成。研究结果显示,血浆中的总激肽原水平在孕期(第15 - 22天)升高,在分娩当天(第22天)达到峰值。这种升高主要是由于与低分子量(LMW)激肽原相比,T - 激肽原增加所致。孕期下丘脑的总激肽原水平无法检测到;然而,垂体前叶的激肽原水平在第15 - 22天显著增加。下丘脑激肽释放酶活性仅在第5 - 20天非常显著地增加,在孕期第21和22天下降。孕期第5 - 20天子宫总激肽原水平较低,仅在第21和22天(分娩当天)显著升高。第21天的这种升高是由于T - 和LMW激肽原水平增加所致。子宫LMW激肽原水平在第21天升高,随后在第22天显著下降。这种下降很可能是由于LMW激肽原产生的缓激肽增加,因为子宫激肽释放酶活性在第21和22天显著升高。分娩当天子宫中缓激肽产生的增加可能在这一过程中子宫收缩激活机制中起重要作用。